Both in Blank Checks

Drugs Made In America Acquisition Corp. Units vs New Providence Acquisition Corp. III Units

Over the past year DMAAU returned +4.2% and NPACU returned +1.2%; their daily moves had a correlation of 0.18.

DMAAU +4.2% NPACU +1.2%Growth of $1, one year, split-adjusted
MetricDMAAUNPACU
Price$10.99$10.51
Market cap$224.2M$283.3M
Today+1.85%+0.10%
1 month—−0.8%
6 months——
Year to date+4.8%—
1 year——
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)—34.5×
Price / sales——
Net cash-$329.7K$63.8K
Dividend yield——
Volatility (60d)—7.0%
Short % of float——
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

DMAAU vs NPACU: Drugs Made In America Acquisition Corp. Units vs New Providence Acquisition Corp. III Units Stock Comparison | Gainbot